This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Dana-Farber-Cancer Institute Inc., Yale University. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,269 
2 out of 1,370 
Years Active: 2017-2020
Title: Innovations and Contributions of Inventor Sang Min Lim
Introduction
Sang Min Lim is a notable inventor based in San Diego, California. He has made significant contributions to the field of biochemistry and pharmacology, particularly in the development of small molecules for therapeutic applications. With a total of 3 patents, his work focuses on innovative solutions for treating proliferative diseases.
Latest Patents
One of Sang Min Lim's latest patents is titled "Hydrophobically tagged small molecules as inducers of protein degradation." This patent provides bifunctional small molecules that bind to kinases, such as the Her3 protein kinase, and includes pharmaceutical compositions for treating various proliferative diseases. Another significant patent is "Ras inhibitors and uses thereof," which describes compounds and methods for treating or preventing cancers and other diseases. These inventions highlight his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Sang Min Lim has worked with prestigious institutions, including the Dana-Farber Cancer Institute and Yale University. His research has focused on developing innovative therapeutic strategies that address critical health challenges. His expertise in small molecule design and application has positioned him as a key figure in his field.
Collaborations
Sang Min Lim has collaborated with esteemed colleagues such as Nathanael Schiander Gray and Ting Xie. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the realm of cancer treatment and other proliferative diseases.
Conclusion
Sang Min Lim's contributions to the field of biochemistry and pharmacology are noteworthy. His innovative patents and collaborations reflect his dedication to advancing medical research and improving therapeutic options for patients. His work continues to inspire future innovations in the treatment of proliferative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile